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Abstract: A newly produced hierarchical, nanoporous carbon (HNC) material is studied for 
the first time in a biological model. The material consists of uniform particles and is character-
ized by a mean diameter ,150 nm, a high specific surface area of 1,000 m2/g, well-developed 
porosity, and high electrical conductivity. These unique properties and ability to transfer charge 
create a possibility of employing HNC as a moderator of tumor cell growth. As the charge of 
HNC may interfere with cell membranes by adhesion and by bonding with cell receptors, it may 
block the supply of nutrients. The interactions of HNC with the U87 cells can also lead to the 
excessive generation of reactive oxygen species (ROS) and activate apoptotic mechanisms in 
cancer cells. The investigation was performed using U87 human glioblastoma and PCS-201–010 
normal fibroblast cell lines, where cell morphology and ultrastructure, viability, ROS produc-
tion, type of cell death, mitochondrial transmembrane potential, and the expression of genes 
engaged in apoptosis pathways are studied. The results demonstrate that cytotoxicity of HNC 
particles increases with concentration from 5 to 100 μg/mL by activation of apoptosis through 
the mitochondrial pathway, without inducing necrosis. Our research indicates the potential 
applicability of HNC in cancer therapy.
Keywords: toxicity, glioblastoma, graphenic carbon material, nanoparticles, U87 cells, fibro-
blast cells
Introduction
Glioblastoma (GB) grade IV is a highly heterogeneous and aggressive primary brain 
tumor.1,2 GB is defined by intensive proliferation and infiltrative growth and is asso-
ciated with astrocytic glioma necrosis, which accounts for most cell death in GB.3 
Despite treatments such as surgical resection, radiotherapy, and chemotherapy, the 
survival of patients diagnosed with GB is just a few months.4,5 Therefore, there is a 
need to implement a future treatment that would involve the use of alternative therapies, 
such as various carbon nanoparaticles. The nanoparticles of different carbon materi-
als were recently widely investigated because of their in vitro and in vivo biological 
activity.6,7 The results of experiments on various carbon nanomaterials have shown 
that their diverse behavior in living organisms may be useful in cancer therapy.8–11 
One of the tested materials was graphene, as previous studies have indicated that it is 
a very promising nanomaterial in treating glioblastoma.12
Graphene is a two-dimensional, one atom-thick layer of sp2 bonded carbon. 
Graphene has been investigated for use in a number of medical and biological areas, 
including drug/gene delivery, cancer therapy, biosensing, bioimaging, antibacterial 
materials, and scaffolds for cell cultures.13–15 However, different forms of graphene, 
correspondence: andré chwalibog
Department of Veterinary and 
animal sciences, University of 
Copenhagen, Groennegaardsvej 3, 
1870 Frederiksberg, Denmark
Tel +45 4096 3573
Fax +45 3533 3020
email ach@sund.ku.dk 
Journal name: International Journal of Nanomedicine
Article Designation: Original Research
Year: 2017
Volume: 12
Running head verso: Jaworski et al
Running head recto: Cytotoxicity of hierarchical nanoporous graphenic carbon
DOI: http://dx.doi.org/10.2147/IJN.S135932
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
17
8.
2 
on
 1
3-
O
ct
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3840
Jaworski et al
such as graphene oxide and reduced graphene oxide produced 
by chemical methods, or pristine graphene produced by 
physical methods, may have different properties.16 Compared 
with graphene oxide, reduced graphene oxide and pristine 
graphene are more likely to diffuse into cancer cells and 
perforate cell membranes.17 Furthermore, amine-modified 
(G-NH
2
) graphene showed no stimulatory effect on human 
platelets and did not induce pulmonary thromboembolism 
in mice. This research suggested that G-NH
2
 is a safe 
biocompatible graphene derivative with potential for bio-
medical applications because of its lack of thrombotic and 
hemolytic activities.18
Although the inhibitory effects of graphene on cancer cell 
growth have been indicated,19 the mechanism of interaction 
with cancer cells is not exactly known. The presence of con-
ductive carbon particles near/inside cells has clear effects on 
their growth, most probably by changing the charge transfer 
between cell receptors. If this theory is true, the application 
of carbon material with a high conductivity and high surface 
area should enhance this interaction effect. A single graphene 
sheet material seems to fulfill this expectation. Unfortunately, 
good-quality graphene sheets have poor N
e
/SSA ratios, where 
N
e
 is the number of edges and SSA is the specific surface 
area per unit mass of material.
Recently, a research group from the Military University 
of Technology, Poland, introduced an original, effortless 
method of production of hierarchical, nanoporous carbon 
(HNC) material prepared from ubiquitous chemical reagents 
like oxalic acid and magnesium.20 In typical reaction per-
formed under vacuum, the Mg/(C
2
H
2
O
4
) mixture reacts 
vigorously upon ignition in self-sustaining regime giving as 
a result carbon material that condenses to uniformly sized, 
spherical hollow and porous carbon nanospheres. Such 
particles are composed of graphene-like mono/multilayers, 
strongly folded and curved with a large number of acces-
sible edges. Such accessible edges are extremely important 
because they are involved in direct contact with living cells, 
penetrating them for instance. Thus, if there are more ones, 
the probability of building theirs into biological material is 
more probable. HNC particles might fulfill these criteria, 
and due to it, high electrical conductivity, ca. 173 S/m, we 
decided to apply HNC in our experiments as moderators of 
tumor cell growth.
Materials and methods
Preparation and characterization of hNc
HNC nanoparticles were synthesized at the Military Uni-
versity of Technology, Warsaw, Poland. The procedure was 
described in detail in a recent paper.20 Fifty grams of stoichio-
metric mixture of magnesium with anhydrous oxalic acid was 
ignited under vacuum condition in 25.7 dm3 volume stainless-
steel reactor. After combustion, raw, black, fluffy product 
was collected and then purified in an aqueous solution of 
HCl (20% wt). After acid treatment, the black powder was 
washed several times with distilled water and finally dried 
under vacuum at 40°C. Dry HNC powder was dispersed in 
ultrapure water to prepare a 1.0 mg/mL solution. After 45 min 
of sonification, the solution was diluted to different con-
centrations with 1× Dulbecco’s Modified Eagle’s Medium 
(DMEM; Sigma-Aldrich Corporation, St Louis, MO, USA) 
immediately prior to exposure to the cells.
The morphology and structure of the obtained materi-
als were studied using a Morada 11 megapixels’ camera 
(Olympus Soft Imaging Solutions, Münster, Germany), 
scanning electron microscope (SEM; FEI QUANTA 
200), transmission electron microscope (TEM; JEM-1220 
JEOL, Tokyo, Japan, accelerating voltage of 80 kV), 
and high-resolution transmission electron microscope 
(HRTEM; TITAN-CUBED 80–300, accelerating voltage 
of 300 kV). Samples for TEM observations were prepared 
by placing droplets of hydrocolloids onto formvar-coated 
copper grids (Agar Scientific, Stansted, UK). Immediately 
after air-drying the droplets, the grids were inserted into 
the microscope.
cell cultures
The human glioblastoma cell line U87 and PCS-201–010 
human skin fibroblasts were obtained from the American 
Type Culture Collection (Manassas, VA, USA) and main-
tained in DMEM containing 10% fetal bovine serum (Life 
Technologies, Houston, TX, USA) and 1% penicillin and 
streptomycin (Life Technologies) at 37°C in a humidified 
atmosphere of 5% CO
2
/95% air in a NuAire DH Auto-
Flow CO
2
 Air-Jacketed Incubator (Plymouth, MN, USA). 
The HNC powder was dispersed in ultrapure water to prepare 
a 1.0 mg/mL stock solution. After 45 min of sonification, the 
solution was diluted to different concentrations with fresh 1× 
DMEM immediately prior to exposure to the cells.
Zeta potential measurements
The zeta potential of HNC was measured using a dynamic 
scattering method. After 45 min of sonification, the stock 
solution (1.0 mg/mL) was diluted to different concentrations 
(5, 10, 20, 50, and 100 μg/mL) with fresh 1× DMEM. Each 
sample was measured after 120 s of stabilization at 25°C in 
three replicates.
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cell morphology
U87 glioma cells and fibroblasts were seeded in six-well 
plates (1×105 cells per well) and incubated for 24 h. Cells cul-
tured in medium without the addition of HNC nanoparticles 
were used as the control. HNC particles were introduced 
to the cells at increasing concentrations (5, 10, 20, 50, and 
100 μg/mL). Cell morphology was recorded using an optical 
microscope 24 h after exposure.
cell ultrastructure
To investigate the cellular ultrastructure, glioma cells were 
washed three times with ice-cold phosphate-buffered saline 
(PBS; Sigma-Aldrich Corporation). The cells were collected 
after centrifugation (1,500 rpm for 5 min) and prefixed with 
2.5% glutaraldehyde, then postfixed in 1% osmium tetroxide, 
dehydrated in ethanol gradients, impregnated with epoxy 
embedding resin (Fluka Epoxy Embedding Medium Kit; 
Sigma-Aldrich) and cut with an ultramicrotome (Leica EM 
UC6). Thin sections were poststained with uranyl acetate 
and lead citrate, and evaluated by a JEM-1220 (Jeol) TEM 
at 80 keV, with a Morada 11 megapixels’ camera (Olympus 
Soft Imaging Solutions).
cell viability
Cell viability was evaluated using a PrestoBlue™ Cell 
Viability Assay (Life Technologies, Taastrup, Denmark). 
PrestoBlue™ reagent is quickly reduced by metabolically 
active cells, providing a quantitative measure of viability 
and cytotoxicity. U87 cells and fibroblasts were plated 
in 96-well plates (5×103 cells per well) and incubated for 
24 h. Then the medium was removed, and samples with the 
HNC particles were introduced to the cells at increasing 
concentrations (5, 10, 20, 50, and 100 μg/mL). After 24 h, 
10 μL of PrestoBlue™ reagent was added to each well 
and incubated for an additional 2 h at 37°C. The optical 
density of each well was recorded at 570 nm on an enzyme-
linked immunosorbent assay reader (Infinite M200, Tecan, 
Durham, NC, USA). Cell viability was expressed as the 
percentage (ODtest - ODblank)/(ODcontrol - ODblank), 
where “ODtest” is the optical density of cells exposed to 
HNC, “ODcontrol” is the optical density of the control 
sample, and “ODblank” is the optical density of wells 
without glioma cells.
reactive oxygen species production
Reactive oxygen species (ROS) production was evaluated 
using DCFDA – Cellular Reactive Oxygen Species Detec-
tion Assay Kit (Abcam, Cambridge, UK). DCFDA uses the 
cell permeant reagent 2′,7′-dichlorofluorescein diacetate, 
a fluorogenic dye that measures hydroxyl, peroxyl, and 
other ROS activities within the cell. After diffusion into 
the cell, DCFDA is deacetylated by cellular esterases to a 
nonfluorescent compound, which is later oxidized by ROS 
into 2′,7′-dichlorofluorescein (DCF). U87 cells were plated 
on opaque-bottomed 96-well plates (3×105 cells per well) 
and incubated for 24 h. Then, the medium was removed, and 
samples with the HNC particles were introduced to the cells. 
HNC particles were diluted in fresh DMEM and hydrocol-
loids were added to cells at increasing concentrations (5, 10, 
20, 50, and 100 μg/mL). After 24 h the medium was removed 
and 100 μL of diluted DCFDA was added to each well and 
incubated for an additional 45 min at 37°C in the dark. DCF 
production was measured by fluorescence spectroscopy with 
excitation wavelength at 485 nm and emission wavelength at 
535 nm on an enzyme-linked immunosorbent assay reader 
(Infinite M200).
apoptosis/necrosis assay
An annexin V/propidium iodide (PI) assay (Alexa Fluor® 
488 Annexin V/Dead Cell Apoptosis Kit with AlexaFluor 
488 Annexin V and PI for flow cytometry, Life Technologies) 
was performed to examine whether cell death had occurred 
by apoptotic or necrotic pathways. After a 24 h incubation 
of U87 glioma cells in 75 mL flasks (1×106 cells per flask), 
the medium was removed, and HNC samples were added 
at 50 μg/mL. After a further 24 h incubation, the medium 
was removed, and the cells were washed in ice-cold PBS. 
Harvested cells were suspended in 100 μL annexin-binding 
buffer (Invitrogen, Carlsbad, CA, USA), and subsequently, 
5 μL of annexin V linked with Alexa Fluor 488 and 1 μL of 
PI were added (Invitrogen). Cells were analyzed using FAC-
Strak (Becton-Dickinson, Germany; software – SimulSet), 
measuring the fluorescence emission at 530 and 575 nm using 
excitation at 488 nm.
Mitochondrial transmembrane potential
The Mitochondrial Transmembrane Potential Apoptosis 
Detection Kit (Abcam) was utilized to examine mitochon-
drial transmembrane potential, an important parameter of 
mitochondrial function used as an indicator of cell death. 
The collapse of the mitochondrial transmembrane potential 
coincides with the opening of the mitochondrial permeability 
transition pores, leading to the release of cytochrome c into 
the cytosol, which in turn triggers other downstream events 
in the apoptotic cascade. In this assay, U87 glioma cells were 
seeded in six-well plates (1×105 cells per well) and incubated 
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for 24 h. Cells cultured in medium without the addition of 
HNC particles were used as the control. HNC particles were 
introduced to the cells at increasing concentrations (5, 10, 20, 
50, and 100 μg/mL). The cells were harvested and suspended 
in 1 mL of the diluted MitoCapture solution. After 20 min 
of incubation with reagent in 37°C and 5% CO
2
, mitochon-
drial permeability was analyzed by using a fluorescence 
microscope (Olympus CKX41, Poland) 24 h after exposure. 
MitoCapture that has aggregated in the mitochondria of 
healthy cells fluoresces red. MitoCapture cannot accumulate 
in mitochondria, remaining as a monomer in the cytoplasm, 
and fluorescing green.
rNa isolation and reverse transcription
In 10 mL of Milli-Q water, 0.01 g of HNC powder was dis-
solved to obtain the concentration of 1,000 μg/mL. Then, 
the prepared stocks of graphene were added to DMEM to 
obtain the concentration of 50 μg/mL of HNC. U87 cells 
were seeded in 75 cm2 culture flasks (1×106 cells per flask) 
and incubated to reach 70% confluency. Then, the cells were 
washed by PBS and subsequently DMEM with HNC was 
added into each flask. After 24 h, cells were disassociated 
by 0.25% trypsin with ethylenediaminetetraacetic acid, har-
vested, and suspended in fresh DMEM medium. Cells were 
then centrifuged at 1,200 rpm for 5 min, washed with PBS, 
and centrifuged to obtain a pellet.
Total RNA was extracted using the PureLink® RNA Mini 
Kit (Ambion™, Life Technologies, Foster City, CA, USA). 
Briefly, the cell pellet was homogenized in RNA Lysis Solu-
tion in a TissueLyser bead mill (Qiagen, Germantown, MD, 
USA) for 5 min at 50 Hz. After centrifugation, the aqueous 
phase was transferred to clean tubes, 70% ethanol was added, 
and the manufacturer’s protocol was followed. RNA quantity 
was determined spectrophotometrically by NanoDrop 2000 
(Thermo Scientific, Wilmington, DE, USA).
The reverse transcription reaction was performed with 
the cDNA High Capacity Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA, USA), using 50 ng of total 
RNA per sample. The concentration of the generated cDNA 
was determined spectrophotometrically by NanoDrop 2000. 
cDNA was stored at -20°C for further analysis.
real-time Pcr
For mRNA expression determination, real-time PCR with 
relative quantification by the ddCt method and normaliza-
tion to a housekeeping gene was performed. TaqMan® Fast 
Advanced Master Mix (Applied Biosystems) with spe-
cific TaqMan probes with primers were used for selected 
genes: caspase-3 (CASP3, inventoried as Hs00234387_m1), 
caspase-9 (CASP9, inventoried as Hs00609647_m1), and the 
housekeeping gene glyceraldehyde-3-phosphate dehydroge-
nase (inventoried as Hs03929097_g1). Runs were performed 
using 50 ng of cDNA per reaction. Reaction conditions were 
set up according to the manufacturer’s protocol. The reaction 
for each sample was performed in duplicate, and the experi-
ment was repeated three times. Reactions were carried out in 
an ABI Prism 7500 Sequence Detection System thermocycler 
(Applied Biosystems). Results were analyzed using ABI 
Prism 7500 relative quantification study software.
statistical analysis
The data were analyzed using monofactorial analysis of 
variance with Statgraphics® Plus 4.1 (StatPoint Technolo-
gies, Warrenton, VA, USA). Mean values are presented with 
standard error. Differences with P,0.05 were considered 
significant.
Results
characterization of hNc
SEM observations showed that the HNC powder consists of 
spheroidal hollow particles of ca. 100–150 nm in diameter. 
These spheres are rather irregular in shape but uniform 
in size (Figure 1A). A closer look at particles using TEM 
microscope (Figure 1B) reveals that such particles consist of 
porous cubes with highly porous and permeable walls, that 
are ca. 30–40 nm thick and are built of disordered carbon 
layers. HRTEM observation (Figure 1C) confirms that the 
walls are composed of randomly crumpled and folded sheets 
give rise to a micro-mesoporous architecture with pores of a 
few Angstroms to several nanometers in size. The structure is 
disordered and rather isotropic, consisting of predominantly 
single carbon layers, with no obvious graphitization. That 
carbon microstructure presents an open, “foam-like” struc-
ture where the cell body has place to build in. High surface 
area (984 m2/g), and micro-mesoporous structure with high 
total volume of pores (2.1 cm3/g) in combination with good 
electrical conductivity (173 S/m) and retained hydrophilic 
character of carbon surface (presence of oxygen-containing 
functionalities)20 fulfill basic requirements in applying them 
in biological field.
Zeta potential measurements
The zeta potential is a key indicator of the stability of colloidal 
dispersions. The magnitude of the zeta potential indicates the 
degree of electrostatic repulsion between adjacent, similarly 
charged particles in a dispersion. Colloids with high zeta 
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potential (negative or positive) are electrically stabilized while 
colloids with low zeta potentials tend to coagulate or flocculate. 
The zeta potential of HNC differed, but all of them generated 
negative values. Increased concentrations of HNC in fresh 
DMEM resulted in decreased negative zeta potential. The mean 
zeta potential was -30.3, -28.3, -28.5, -25.4, and -21.5 for 
5, 10, 20, 50, and 100 μg/mL of HNC, respectively. These 
values indicate moderate stability of the colloid.
cell morphology
In preliminary experiments with PCS-201–010 fibroblasts, 
the cellular morphology after treatment with HNC differed 
from that of the control group. Fewer cells were seen with 
HNC agglomerates attached to the cell body (Figure 2). 
In U87 glioma cells and fibroblasts, it was noticeable that 
HNC agglomerates attached to the cell body and to protru-
sions. The HNC-treated cells were more oval and denser, 
and their protrusions were shorter in comparison with the 
control cells (Figure 2).
TeM analysis of cells
The TEM images showed a typical ultrastructure of glioma 
cells (Figure 3). Cell structures (nucleus, mitochondria, vacu-
oles, Golgi apparatus, rough endoplasmic reticulum) were 
visible in the control group. The nuclei were elongated and 
had an irregular shape and unevenly distributed chromatin. 
Each cell had mitochondria that varied in size and shape, 
but most were usually oval or elongated. We observed that 
HNC caused changes in the cell ultrastructure. A fraction 
of HNC-treated glioma cells was deformed. Inside the cell, 
cell structures also had different morphology compared to 
the control group. In the HNC-treated group, endoplasmic 
reticulum was less visible and mitochondrial crests were 
destroyed. We also found HNC agglomerates inside the cells 
in vacuoles and cytoplasm.
cell viability
This assay is based on the ability of metabolically active 
cells to reduce the PrestoBlue™ reagent. The greater the 
number of active cells in the well, the greater the activity 
of cellular enzymes, resulting in a lower concentration of 
the dye, which can then be measured and quantified. HNC 
significantly (P,0.05) decreased the viability of both cell 
lines compared with the control group. However, the reduc-
tion in viability of glioma cells was significantly higher than 
that of fibroblast cells. Increased concentrations of HNC 
resulted in decreased vitality in U87 cells. The lowest vitality 
was observed at a concentration of 100 μg/mL: 56%±3.4%, 
and the lowest vitality in the PCS-201–010 fibroblast 
cells was also observed at a concentration of 100 μg/mL: 
82%±2.4% (Figure 4).
rOs production
Low levels (or optimum levels) of ROS play an important 
role in signaling pathways. However, when ROS production 
increases and overwhelms the cellular antioxidant capacity, 
it can induce macromolecular damage (by reacting with 
DNA, proteins, and lipids) and disrupt thiol redox circuits. 
Figure 1 scanning electron microscope and TeM images of hierarchical, nanoporous graphenic carbon particles.
Notes: Uniform hollow spheres with an average diameter of 100–150 nm are observed (A). TeM images (B and C) show that each particle is built from porous walls without 
obvious graphitization, and composed of several nanometers-long highly curved sp2 sheets.
Abbreviation: TeM, transmission electron microscope.
?????????????????
? ? ?
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Figure 2 Morphology of U87 glioma (A and B) and PCS-201–010 fibroblast (C and D) cells: untreated control (A and C), treated with hNc particles (B and D).
Note: arrows point to hNc agglomerates.
Abbreviation: hNc, hierarchical, nanoporous carbon.
? ?
? ?
????? ?????
????? ?????
Figure 3 glioma U87 cells ultrastructure from control group (A) after hierarchical, nanoporous graphenic carbon particles treatment (B, C, and D).
Notes: scale bar: A and C – 1 μm, B – 5 μm, D – 500 nm.
Abbreviations: ga, golgi apparatus; er, rough endoplasmic reticulum; hNc, hierarchical, nanoporous carbon; M, mitochondrion; N, nucleus; V, vacuole.
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In the first instance, damage can lead to apoptosis or necrosis. 
Disruption of thiol redox circuits can lead to aberrant cell 
signaling and dysfunctional redox control. HNC significantly 
(P,0.05) increased the ROS production of U87 cell com-
pared with the control group. Increased concentrations of 
HNC particles resulted in increased ROS generation in U87 
glioma cells. The highest was observed at a concentration 
of 100 μg/mL (Figure 5).
apoptosis
The Alexa Fluor 488 Annexin V/PI assay (Alexa Fluor 488 
Annexin V/Dead Cell Apoptosis Kit) was used to monitor 
phosphatidylserine (PS) translocation due to apoptosis. Soon 
after apoptosis is induced, PS is translocated from the inner 
leaflet of the plasma membrane to the outer leaflet. HNC 
induced apoptosis in U87 cells. The degree of apoptosis 
increased in glioma cells to 38%, whereas the degree of 
necrosis in U87 cells remained low, at ~1% (Figure 6).
Mitochondrial transmembrane potential
Disintegration of the mitochondrial membranes is one of 
the first changes inside the cell that occurs upon initia-
tion of apoptosis. Healthy cells have active mitochondria; 
therefore, they collect aggregates of the red dye inside 
Figure 4 Effect of HNC particles on the viability of U87 glioma (red) and PCS-201–010 fibroblast (blue) cells.
Notes: The columns with different letters (a–c) indicate significant differences between the concentrations (P=0.001); error bars are standard deviations. c – control group 
(untreated cells).
Abbreviation: hNc, hierarchical, nanoporous carbon.
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Figure 5 effect of hNc particles on the rOs production of glioma U87 cells.
Notes: The columns with different letters (a–d) indicate significant differences between the concentrations (P=0.000); error bars are standard deviations. c – control group 
(untreated cells).
Abbreviations: hNc, hierarchical, nanoporous carbon; rOs, reactive oxygen species. 
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Table 1 CASP3 and CASP9 mrNa ratio in U87 cells treated 
with hNc calculated in proportion to untreated (control) cells, 
normalized to GAPDH housekeeping gene
Level of mRNA 
expression
Groups Analysis of variance
Control HNC Standard 
error-pooled
P-value
CASP3/GAPDH 1.05a 1.85b 0.084 0.0013
CASP9/GAPDH 0.98a 1.29b 0.033 0.0015
Note: a,bValues within rows with different superscripts are significantly different.
Abbreviations: CASP3, caspase 3; CASP9, caspase 9; GAPDH glyceraldehyde-3-
phosphate dehydrogenase; hNc, hierarchical, nanoporous carbon.
Figure 6 analysis of apoptosis.
Notes: (A) annexin V-alexa Fluor® 488 and PI assay analysis. scatter diagrams of control cells (A1) and exposed to 50 μg/ml of hNc particles (A2). (B–D) Investigation of 
mitochondrial transmembrane potential, B – control cells, C – cells exposed to 20 μg/ml of hNc particles, D – cells exposed to 50 μg/mL of HNC particles. Magnification 200×.
Abbreviations: hNc, hierarchical, nanoporous carbon; PI, propidium iodide.
?
? ??
? ?
?????
?
??? ??? ????????????
??
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???
them, which are visualized with fluorescence microscopy. 
In apoptotic cells, the green dye cannot accumulate in 
mitochondria; hence, it stays in the cytoplasm. Our control 
group had a large number of working mitochondria, 
and they remained red in color (Figure 6B). The mito-
chondria of the cells treated with HNC at a concentra-
tion of 50 μg/mL were entirely damaged (Figure 5D).
real-time Pcr
Two genes involved in the apoptosis process, CASP3 
and CASP9, were investigated. CASP3 is activated in the 
apoptotic cell both by extrinsic (death ligand) and intrinsic 
(mitochondrial) pathways; CASP9 has been linked to the 
mitochondrial death pathway. The expression of CASP3 
and CASP9 was significantly higher in comparison with the 
control group (Table 1).
Discussion
In this study, for the first time, we examined the potential 
toxicity of HNC nanoparticles. We treated glioma cells and 
human skin fibroblasts with HNC at different concentra-
tions (5, 10, 20, 50, and 100 μg/mL), which were based on 
similar research on the use of graphene and other carbon 
nanoparticles.19,21 In either case, the base structure of the nano-
particles is very similar, consisting of very thin petals, down to 
one layer of carbon atoms. Therefore, with this similarity, we 
expected comparable effects on glioma cells after treatment.
We achieved promising results in our previous studies 
with nanodiamond22 and graphene12,21 in glioma therapy, and 
we expect the same outcome with HNC nanoparticles. The 
aim was to test their biological activity in in vitro cell culture 
by examining the changes in cell morphology and viability, 
and quantifying cell death.
Visualization of HNC particles showed the unique archi-
tecture of the tested particles, unparalleled by other carbon 
materials. Their hierarchical porous structure containing 
micro-, meso-, and macropores and a good electrical con-
ductivity and hydrophilic character provide a highly electro-
chemically active surface area, short diffusion distance, and 
a high mass-transfer rate.20 In our experiments, we noted a 
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strong tendency for the HNC particles to be localized closed 
to the glioma cells, indicating an affinity of HNC for the cells. 
Microscopic observations showed a significant difference 
in morphology between control and treated cells after 24 h 
of culturing in a medium with HNC. The light microscopy 
images (Figure 2) suggest that HNC has a strong affinity for 
the cell body, previously described in relation to graphene and 
different carbon allotropes.17,21 On light microscope images, 
it was seen that the cells treated with higher concentrations 
(20, 50, and 100 μg/mL) were more oval and denser and their 
protrusions were shorter in comparison with the control cells. 
The lower concentrations of HNC particles (5, 10 μg/mL) 
did not cause noticeable effects. At each concentration, HNC 
particles accumulated, especially near cell agglomerates. The 
agglomerates of HNC particles were also observed inside 
the U87 cells. In our previous study with different carbon 
nanoparticles, we have observed nanoparticles appearing on 
the bright field microphotographs as black dots, aggregated 
inside the cells or on the cell surface.23 However, to determine 
the exact interaction of nanoparticles with the cell membrane, 
further studies need to be conducted.
Assessment of cell viability after incubation with HNC 
showed that the particles have a toxic effect at higher con-
centrations (50 and 100 μg/mL). The results are consistent 
with the fact that dose is an important factor in the toxicity 
of carbon nanoparticles.23,24 However, the toxic effects also 
depend on the type of cells, as it was observed that fibroblasts 
(Figure 4) were less susceptible to HNC treatment than 
glioma cells. This might be explained by the high amount 
of HNC aggregates in fibroblast medium and lower affinity 
of the HNC particles to fibroblast cells, influencing adhesion 
to the cell membrane and probably HNC intake by cells. 
In comparison to normal (healthy) cells, cancer cells have 
high proliferation potential and high metabolic rate because 
of loss of the control of cell cycle, and they need to absorb 
precursors to build cell structures.
Cytotoxicity studies of graphene and related materials 
include the influence on the cell viability and morphology, 
membrane integrity, ROS generation, DNA damage, gene 
expression, and a mechanism of uptake.25 Oxidative stress 
and generation of ROS can be involved in the toxic effects of 
graphene-based nanomaterials.26 Assessment of ROS produc-
tion showed a toxic influence of HNC on glioma cells. The 
interactions of the HNC particles with the U87 cells can lead 
to excessive ROS generation. HNC can induce dissipation of 
the mitochondrial membrane potential, which subsequently 
increases the generation of intracellular ROS and triggers 
apoptosis by activating the mitochondrial pathway.
Most cancer cells are highly resistant to apoptosis; 
hence, programmed cell death is crucial in cancer treatment 
because too little apoptosis results in malignant, not dying, 
cells.27 Therefore, our further research was focused on 
defining the pathway of cell death by using flow cytometry, 
analyzing mitochondrial transmembrane potential, and 
quantifying the expression of the main apoptosis markers, 
CASP3 and CASP9.
The results from the Annexin V/PI test have shown a 
predominance of apoptotic cells over necrotic ones. In com-
parison with control cells, the rate of apoptosis increased to 
38%. The degree of necrosis was insignificant, around 1% 
(Figure 6). Apoptosis is a coordinated process that can be 
triggered through two different pathways: the death receptor 
pathway located on the cell membrane and the mitochondrial 
pathway. Theoretically, both these pathways could be trig-
gered because HNC could interact with death receptors on 
the cell membrane, and we also observed degradation of 
mitochondria in HNC-treated cells. HNC may also interact 
with cell membrane surface receptors to block the transport 
of various substances into the cell, inducing cellular stress 
and apoptosis. However, the mechanism of apoptosis is still 
unknown. Caspases are paramount markers, which activate 
the apoptosis process.28 CASP3 is the main protein that takes 
part in both pathways in programmed cell death. The real-
time PCR results have confirmed the activation of apoptotic 
processes. In HNC-treated glioma cells, the expression of 
CASP3 was higher (Table 1) than in the control group.
To provide the whole perspective on apoptosis, we con-
ducted an alternative test, which verified the destruction of 
mitochondrial membranes and established the activation of 
apoptosis in the mitochondrial pathway. On the fluorescent 
microscopy image with the concentration of 50 μg/mL of 
HNC, where the only green color is seen, mitochondria 
are deactivated (Figure 6). Furthermore, a lower number 
and damaged mitochondria were observed. HNC particles 
probably enter the cells and interact with the mitochondrial 
membrane, which results in cytokine secretion and activa-
tion of CASP9. Consequently, the expression of CASP9 was 
increased significantly compared with the control group.
Taking into consideration how HNC particles behave in 
the cancer cell environment and that they induce cell death 
through apoptosis, we assume that these carbon nanoparticles 
may be a useful agent in cancer therapies. Their toxicity 
exhibits dose dependence. Therefore, the dose must be 
very carefully selected in future cancer therapies. Carbon 
nanoparticles are already used in drug delivery.29,30 HNC 
particles may also be potential nanocarriers; they have a 
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relatively high surface area (up to 1,000 m2/g), which may 
be used for functionalization, and they can act as a host for 
many diverse molecules.20
The present results are preliminary, and a follow-up 
research elucidating molecular mechanisms of interactions 
between HNC and cells is necessary. At this stage, the results 
indicate that the contact between HNC and U87 cell mem-
branes may be the key cause of HNC particles’ toxicity.
Conclusion
The results demonstrate that cytotoxicity of HNC particles 
increases with concentration. Contact between HNC and 
glioma inner and outer cell membranes may be the key cause 
of toxicity. Moreover, they only activate apoptosis through 
the mitochondrial pathway, without inducing necrosis. Our 
research indicates the potential applicability of HNC in 
cancer therapy.
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